Immune Pharmaceuticals Expands Immuno-Dermatology Development Portfolio With Topical Nano-Formulated Cyclosporine A
June 10, 2015 at 08:04 AM EDT
Immune Pharmaceuticals Inc. (NASDAQ: IMNP) announced today that it has entered into a binding Memorandum of Understanding with Yissum, ...
